Increased iron level in motor cortex of amyotrophic lateral sclerosis patients: An in vivo MR study

Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration

Volumn 15, Issue 5-6, 2014, Pages 357-361

  Yu, Jixu ^a   Qi, Faying ^a   Wang, Nian ^a   Gao, Peihong ^a   Dai, Shouping ^a   Lu, Yucheng ^a   Su, Quanping ^a   Du, Yifeng ^b   Che, Fengyuan ^a  

^a LINYI PEOPLE'S HOSPITAL   (China)

^b SHANDONG PROVINCIAL HOSPITAL AFFILIATED TO SHANDONG UNIVERSITY   (China)

Author keywords

Amyotrophic lateral sclerosis; Iron; Magnetic resonance imaging; Susceptibility weighted imaging

Indexed keywords

IRON;

ADULT; AGED; AMYOTROPHIC LATERAL SCLEROSIS; ARTICLE; BRAIN LEVEL; BRAIN SCINTISCANNING; CAUDATE NUCLEUS; CLINICAL ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; DISEASE COURSE; FEMALE; GLOBUS PALLIDUS; HOMEOSTASIS; HUMAN; MALE; MOTONEURON; MOTOR CORTEX; NUCLEAR MAGNETIC RESONANCE IMAGING; NUCLEAR MAGNETIC RESONANCE SCANNER; PRIORITY JOURNAL; PUTAMEN; RED NUCLEUS; SUBSTANTIA NIGRA; SUSCEPTIBILITY WEIGHTED IMAGING; ANALYSIS OF VARIANCE; COHORT ANALYSIS; HEMISPHERIC DOMINANCE; METABOLISM; MIDDLE AGED; PATHOLOGY; THREE DIMENSIONAL IMAGING;

ADULT; AGED; AMYOTROPHIC LATERAL SCLEROSIS; ANALYSIS OF VARIANCE; COHORT STUDIES; DISEASE PROGRESSION; FEMALE; FUNCTIONAL LATERALITY; HUMANS; IMAGING, THREE-DIMENSIONAL; IRON; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; MOTOR CORTEX;

EID: 84906343023     PISSN: 21678421     EISSN: 21679223     Source Type: Journal    
DOI: 10.3109/21678421.2014.906618     Document Type: Article

References (29)

1. Redler RL, Dokholyan NV. The complex molecular biology of amyotrophic lateral sclerosis (ALS). Prog Mol Biol Transl Sci. 2012; 107: 215-62
2. Taylor J P, Hardy J, Fischbeck K H. Toxic proteins in neurodegenerative disease. Science. 2002; 296: 1991-5
3. Hadzhieva M, Kirches E, Wilisch-Neumann A, Pachow D, Wallesch M, Schoenfeld P, et al. Dysregulation of iron protein expression in the G93A model of amyotrophic lateral sclerosis. Neuroscience. 2013; 230: 94-101
4. Oshiro S, Morioka MS, Kikuchi M. Dysregulation of iron metabolism in Alzheimer' s disease, Parkinson' s disease, and amyotrophic lateral sclerosis. Adv Pharmacol Sci. 2011; 2011: 378278
5. Kwan J Y, Jeong S Y, van Gelderen P, Deng H X, Quezado M M, Danielian LE, et al. Iron accumulation in deep cortical layers accounts for MRI signal abnormalities in ALS: Correlating 7 Tesla MRI and pathology. PLoS One. 2012; 7: E35241
6. Contestabile A. Amyotrophic lateral sclerosis: From research to therapeutic attempts and therapeutic perspectives. Curr Med Chem. 2011; 18: 5655-65
7. Jomova K, Vondrakova D, Lawson M, Valko M. Metals, oxidative stress and neurodegenerative disorders. Mol Cell Biochem. 2010; 345: 91-104
8. Petri S, Körner S, Kiaei M. Nrf2/ARE Signaling Pathway: Key Mediator in Oxidative Stress and Potential Therapeutic Target in ALS. Neurol Res Int. 2012; 2012: 878030
9. Gelman N, Gorell J M, Barker P B, Savage R M, Spickler E M, Windham JP, et al. MR imaging of human brain at 3.0 T: Preliminary report on transverse relaxation rates and relation to estimated iron content. Radiology. 1999; 210: 759-67
10. Ordidge R J, Gorell J M, Deniau J C, Knight R A, Helpern J A. Assessment of relative brain iron concentrations using T2-weighted and T2-weighted MRI at 3 Tesla. Magn Reson Med. 1994; 32: 335-41
11. Schenck J F, Zimmerman E A. High-field magnetic resonance imaging of brain iron: Birth of a biomarker? NMR Biomed. 2004; 17: 433-45
12. Haacke E M, Ayaz M, Khan A, Manova E S, Krishnamurthy B, Gollapalli L, et al. Establishing a baseline phase behaviour in magnetic resonance imaging to determine normal vs. abnormal iron content in the brain. JMagn Reson Imaging. 2007; 26: 256-64
13. Haacke E M, Makki M, Ge Y, Maheshwari M, Sehgal V, Hu J, et al. Characterizing iron deposition in multiple sclerosis lesions using susceptibility weighted imaging. JMagn Reson Imaging. 2009; 29: 537-44
14. Brooks BR. El Escorial World Federation of Neurology criteria for the diagnosis of amyotrophic lateral sclerosis. JNeurol Sci. 1994; 124 (Suppl): 96-107
15. Haacke E M, Miao Y, Liu M, Habib C A, Katkuri Y, Liu T, et al. Correlation of putative iron content as represented by changes in R2 and phase with age in deep grey matter of healthy adults. JMagn Reson Imaging. 2010; 32: 561-76
16. Kollewe K, Mauss U, KrampflK, Petri S, Dengler R, Mohammadi B. ALSFRS-R score and its ratio: A useful predictor for ALS progression. JNeurol Sci. 2008; 275: 69-73
17. Olsen M K, Roberds S L, Ellerbrock B R, Fleck TJ, McKinley DK, Gurney ME. Disease mechanisms revealed by transcription profiling in SOD1-G93A transgenic mouse spinal cord. Ann Neurol. 2001; 50: 730-40
18. Mitchell R M, Simmons Z, Beard J L, Stephens H E, Connor JR. Plasma biomarkers associated with ALS and their relationship to iron homeostasis. Muscle Nerve. 2010; 42: 95-103
19. Kasarskis E J, Tandon L, Lovell M A, Ehmann WD. Aluminum, calcium, and iron in the spinal cord of patients with sporadic amyotrophic lateral sclerosis using laser microprobe mass spectroscopy: A preliminary study. JNeurol Sci. 1995; 130: 203-8
20. Mizuno Y, Amari M, Takatama M, Aizawa H, Mihara B, Okamoto K. Transferrin localizes in Bunina bodies in amyotrophic lateral sclerosis. Acta Neuropathol. 2006; 112: 597-603
21. Langkammer C, Enzinger C, Quasthoff S, Grafenauer P, Soellinger M, Fazekas F, et al. Mapping of iron deposition in conjunction with assessment of nerve fibre tract integrity in amyotrophic lateral sclerosis. JMagn Reson Imaging. 2010; 31: 1339-45
22. Zhang J, Zhang Y, Wang J, Cai P, Luo C, Qian Z, et al. Characterizing iron deposition in Parkinson's disease using susceptibility-weighted imaging: An in vivo MR study. Brain Res. 2010; 1330: 124-30
23. Oba H, Araki T, Ohtomo K, Monzawa S, Uchiyama G, Koizumi K, et al. Amyotrophic lateral sclerosis: T2 shortening in motor cortex at MR imaging. Radiology. 1993; 189: 843-6
24. Hallgren B, Sourander P. The effect of age on non-haemin iron in the human brain. JNeurochem. 1958; 3: 41-51
25. Walsh A J, Wilman A H. Susceptibility phase imaging with comparison to R2 mapping of iron-rich deep grey matter. Neuroimage. 2011; 57: 452-61
26. Hecht MJ, Fellner C, Schmid A, Neund ör fer B, Fellner FA. Cortical T2 signal shortening in amyotrophic lateral sclerosis is not due to iron deposits. Neuroradiology. 2005; 47: 805-8
27. Bowen BC, Pattany PM, Bradley WG, Murdoch JB, Rotta F, Younis AA, et al. MR imaging and localized proton spectroscopy of the precentral gyrus in amyotrophic lateral sclerosis. AJNR Am J Neuroradiol. 2000; 21: 647-58
28. Haacke EM, Xu Y, Cheng YC, Reichenbach JR. Susceptibility weighted imaging (SWI). Magn Reson Med. 2004; 52: 612-8
29. Xu X, Wang Q, Zhang M. Age, gender, and hemispheric differences in iron deposition in the human brain: An in vivo MRI study. Neuroimage. 2008; 40: 35-42